Regulators of G Protein Signaling Dynamics

G protein-coupled receptors (GPCRs) translate diverse extracellular cues into intracellular responses via heterotrimeric G proteins. The temporal precision and amplitude of these signals are governed by regulator of G protein signalling (RGS) proteins, a family of GTPase-accelerating proteins (GAPs) that bind Gα subunits and promote GTP hydrolysis. By shortening the active, GTP-bound state of Gα, RGS proteins impose rapid termination of signals, confer receptor-to-effector specificity and sculpt signalling gradients within cells. Beyond canonical GAP activity, many RGS family members contain additional domains—such as PDZ, DEP or GGL motifs—that facilitate interactions with scaffolds, receptors and downstream effectors, thereby coordinating the assembly of signalosomes and modulating pathway crosstalk. Dynamic regulation of RGS expression, localisation and post-translational modification further tunes GPCR responsiveness in real time. Dysregulation of RGS-mediated kinetics underlies pathologies ranging from cardiovascular inflammation to cancer and neurological disorders. Consequently, RGS proteins have emerged as promising targets for next-generation modulators of GPCR networks, with the potential to refine therapeutic interventions, minimise off-target effects and restore homeostatic balance in disease settings.

Research from Nature Portfolio

Recent studies have illuminated how selective inactivation of G protein signalling by RGS proteins governs immune cell behaviour in vascular inflammation. Work on RGS1 has revealed that its upregulation within atherosclerotic plaques attenuates chemokine-driven Gα signalling, limiting macrophage chemotaxis and retention. In mouse models, loss of RGS1 exacerbates leukocyte accumulation, promotes plaque instability and heightens susceptibility to Angiotensin II-induced aneurysm formation. These findings underscore the crucial role of RGS1 in controlling the spatial and temporal dimensions of chemokine receptor signalling during chronic vascular disease and highlight the therapeutic promise of modulating RGS-dependent desensitisation to restrain inflammation.

Regulators of G Protein Signaling Dynamics publication trend

The graph below shows the total number of articles in regulators of g protein signaling dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

G protein-coupled receptor (GPCR): A membrane protein that transduces extracellular stimuli into intracellular G protein activation.

GTPase-accelerating protein (GAP): A factor that increases the intrinsic GTP-hydrolysis rate of Gα subunits, terminating the signal.

Gα subunit: The guanine nucleotide-binding component of heterotrimeric G proteins; active when GTP-bound.

Signalosome: A multiprotein complex organising receptors, kinases and regulatory proteins to coordinate signalling specificity.

References

1. Regulator of G protein signaling protein 6 alleviates acute lung injury by inhibiting inflammation and promoting cell self-renewal in mice. Cellular & Molecular Biology Letters (2023).
2. Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling. Cell Death & Disease (2024).
3. Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials. Journal of Biological Chemistry (2019).
4. A Global Map of G Protein Signaling Regulation by RGS Proteins. Cell (2020).
5. RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling. Nature Communications (2015).